Breast Cancer
రొమ్ము క్యాన్సర్
Subtype-led treatment of ER+, HER2+, and triple-negative breast cancer — chemotherapy, hormonal, and targeted therapy.
Medical Oncologist, Hemato-Oncologist & Bone Marrow Transplant Physician — practising at KIMS-Sunshine Hospitals, Begumpet and Peoples Polyclinic, Manikonda, Hyderabad.
I'm a medical oncologist treating the full range of adult cancers — breast, lung, gastrointestinal, gynaecologic, and head & neck tumours — alongside blood cancers. Additional fellowship training in bone marrow transplantation means the most complex cases and everyday cancer care are managed with the same depth.
My foundation is a DM in Medical Oncology from Nizam's Institute of Medical Sciences (NIMS), Hyderabad — training that spans the whole spectrum of cancer, solid tumours and blood cancers alike. I then sub-specialised at Vancouver General Hospital, Canada, one of North America's premier centres for stem cell transplantation, layering transplant and cellular-therapy expertise on top of a broad medical-oncology practice.
Today I see patients across solid-tumour and haematological cancers at KIMS-Sunshine Hospitals, Begumpet and Peoples Polyclinic, Manikonda — combining day-to-day treatment planning, chemotherapy, targeted and hormonal therapy, and second opinions with the option of advanced cellular therapy when it's needed. My work has also been featured in national media and television.
These sit alongside — not instead of — a full solid-tumour practice and peer-reviewed research across both fields (see publications).
I also offer CAR T-cell therapy and advanced immunotherapies for selected blood and solid cancers. For guidance on choosing an oncologist in Hyderabad, see Best Oncologist in Hyderabad.
A diagnosis changes everything. How you're guided through it should be steady, honest, and built around you. Four things you can count on:
Every patient is different — not just in diagnosis, but in priorities, fears, and goals. My role is to walk alongside you with clarity and conviction, helping you navigate a complex journey.
My decisions are rooted in current evidence — but I won't reduce you to a number. If a treatment causes more harm than benefit, or the direction stops matching your values, I'll revisit the plan honestly and transparently.
You can expect medical expertise alongside plain honesty and respect for your time and emotions — answers to difficult questions, progress celebrated openly, and decisions that feel right for you.
Cancer care can feel overwhelming. With the right guidance it can also feel purposeful. My goal is for you to feel informed, supported, and empowered — even on the toughest days.
A medical-oncology practice that spans solid tumours and blood cancers — with advanced transplant and cellular therapy available when a case calls for it.
Subtype-led treatment of ER+, HER2+, and triple-negative breast cancer — chemotherapy, hormonal, and targeted therapy.
NSCLC and SCLC, including mutation-driven disease (EGFR, ALK, ROS1) increasingly seen in non-smokers.
Colorectal, stomach, and other GI cancers — chemotherapy, targeted therapy, and immunotherapy by biomarker.
Cervical, ovarian, and prostate cancers — with BRCA-guided and hormone-based strategies.
Oral, throat, and laryngeal cancers — combined chemoradiation and systemic therapy.
Diagnosis and treatment of acute and chronic leukemias including AML, ALL, CML, and CLL.
ల్యూకేమియా (రక్త క్యాన్సర్) చికిత్సలో అనుభవం.
Comprehensive care for Hodgkin and Non-Hodgkin lymphomas with advanced protocols.
లింఫోమా చికిత్సలో ప్రత్యేక నైపుణ్యం.
Evidence-based treatment of multiple myeloma with a focus on quality of life and long-term control.
మల్టిపుల్ మైలోమా చికిత్సలో అనుభవం.
Autologous, matched sibling, and haploidentical transplants for blood cancers.
బోన్ మారో ట్రాన్స్ప్లాంట్లతో ఎన్నోఏళ్ల అనుభవం.
Advanced cellular therapy for refractory leukemia and lymphoma in select patients.
సెల్ థెరపీ (CAR-T) లో నైపుణ్యం.
Focused treatment of childhood leukemias and lymphomas, balancing cure with care.
Relief from cancer symptoms, pain, and side effects through personalized care planning.
పాలియేటివ్ కేర్ మరియు సపోర్టివ్ ట్రీట్మెంట్ నైపుణ్యం.
Selected peer-reviewed research in hematology, oncology, and stem cell transplantation
Mutation analysis in CML patients who failed imatinib, guiding next-line tyrosine kinase inhibitor selection.
BloodLong-term outcomes and late effects in South Indian children with Hodgkin lymphoma.
Annals of OncologyReal-world evidence on whether early PET response predicts Hodgkin lymphoma outcome.
JCO Global OncologyDosage modifications and outcomes in high-risk APL with triple therapy (ATRA, ATO, daunorubicin).
JCO Global OncologyData from this work was presented as an oral presentation at the American Society of Hematology (ASH) Annual Meeting, 2015.
Cost-effectiveness and survival outcomes with generic imatinib in CML.
Clinical Lymphoma Myeloma and LeukemiaSouth Indian multicenter study comparing BCR-ABL1 halving time with day-90 response in CML.
Clinical Lymphoma Myeloma and LeukemiaEight-year experience treating Ph+ ALL at a tertiary cancer center in India.
South Asian Journal of CancerAdiponectin, leptin, and their ratio as potential risk biomarkers in obesity-related breast cancer.
Indian Journal of Medical and Paediatric OncologyFive-year experience with peptide receptor radionuclide therapy in neuroendocrine tumors.
European Journal of Nuclear Medicine and Molecular Imaging